Skip to content

the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation

the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation: Randomized Control Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06762210
Enrollment
300
Registered
2025-01-07
Start date
2026-02-12
Completion date
2026-09-01
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation; Tobacco Dependence

Keywords

Smoking cessation, oral health

Brief summary

Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.

Detailed description

Oral health deterioration is a well-documented consequence of smoking, including periodontal disease, tooth discoloration, and oral cancer. Recent advancements in artificial intelligence (AI) have led to the development of AI Molar Mind, a digital tool designed to assess oral health and provide personalized feedback to motivate behavioral change. This study aims to evaluate the efficacy of AI Molar Mind in aiding smoking cessation by leveraging oral health evaluations as a motivational tool.

Interventions

OTHERAI Molar Mind

a baseline oral health assessment using AI Molar Mind, which analyzes intraoral images and self-reported oral health data.

Sponsors

Fayoum University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

A randomized, controlled, single-blind clinical trial with two parallel arms.

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-65 years * smoke ≥5 cigarettes per day * motivated to quit smoking, * have access to a smartphone or computer

Exclusion criteria

* Pregnant women * individuals with severe psychiatric conditions * those already using other smoking cessation therapies.

Design outcomes

Primary

MeasureTime frameDescription
smoking cessation indicatorbase line, 6-month post smoking cessationBiochemically verified smoking cessation at 6 months (measured by exhaled carbon monoxide levels \<6 ppm).

Countries

Egypt

Contacts

CONTACTAlshaimaa shabaan, PhD
aas16@fayoum.edu.eg00201006047940
PRINCIPAL_INVESTIGATORAlshaimaa Mohamed, PhD

Fayoum University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026